Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure

Hepatology

Volumn 58, Issue 1, 2013, Pages 304-313

  Stravitz, R Todd ^a   Bowling, Regina ^b   Bradford, Robert L ^c   Key, Nigel S ^c   Glover, Sam ^b   Thacker, Leroy R ^a   Gabriel, Don A ^b,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Invitrox Inc   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CREATININE; FIBRINOGEN RECEPTOR; PHOSPHATE; PROCOAGULANT;

ACUTE LIVER FAILURE; ADULT; ADVERSE OUTCOME; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER INJURY; MALE; MEMBRANE MICROPARTICLE; OUTCOME ASSESSMENT; PARTICLE SIZE; PRIORITY JOURNAL; SURVIVOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; CELL-DERIVED MICROPARTICLES; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; PLATELET MEMBRANE GLYCOPROTEIN IIB; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOPLASTIN;

EID: 84879605525     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26307     Document Type: Article

References (40)

1. Bernal W, Auzinger G, Sizer E, Wendon J. Intensive care management of acute liver failure. Semin Liver Dis 2008; 28: 188-200.
2. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. HEPATOLOGY 2000; 32: 734-739.
3. Stravitz RT, Kramer DJ. Management of acute liver failure. Nat Rev Gastroenterol Hepatol 2009; 6: 542-553.
4. Antoniades CG, Berry PA, Wendon JA, Vergani D. The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol 2008; 49: 845-861.
5. Munoz SJ, Stravitz RT, Gabriel DA. Coagulopathy of acute liver failure. Clin Liver Dis 2009; 13: 95-107.
6. Stravitz RT, Lisman T, Luketic VA, Sterling RK, Puri P, Fuchs M, et al. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol 2012; 56: 129-136.
7. Ganey PE, Luyendyk JP, Newport SW, Eagle TM, Maddox JF, Mackman N, et al. Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice. HEPATOLOGY 2007; 46: 1177-1186.
8. Lisman T, Bakhtiari K, Adelmeijer J, Meijers JC, Porte RJ, Stravitz RT. Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure. J Thromb Haemost 2012; 10: 1312-1319.
9. Agarwal B, Wright G, Gatt A, Riddell A, Vemela V, Mallett S, et al. Evaluation of coagulation abnormalities in acute liver failure. J Hepatol 2012; 57: 780-786.
10. Pereira LM, Langley PG, Hayllar KM, Tredger JM, Williams R. Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators. Gut 1992; 33: 98-102.
11. Schiodt FV, Balko J, Schilsky M, Harrison ME, Thornton A, Lee WM. Thrombopoietin in acute liver failure. HEPATOLOGY 2003; 37: 558-561.
12. Stephan F, Hollande J, Richard O, Cheffi A, Maier-Redelsperger M, Flahault A. Thrombocytopenia in a surgical ICU. Chest 1999; 115: 1363-1370.
13. Olmez I, Zafar M, Shahid M, Amarillo S, Mansfield R. Analysis of significant decrease in platelet count and thrombocytopenia, graded according to NCI-CTC, as prognostic risk markers for mortality and morbidity. J Pediatr Hematol Oncol 2011; 33: 585-588.
14. Baughman RP, Lower EE, Flessa HC, Tollerud DJ. Thrombocytopenia in the intensive care unit. Chest 1993; 104: 1243-1247.
15. Moreau D, Timsit JF, Vesin A, Garrouste-Org, de Lassence A, Zahar JR, et al. Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays. Chest 2007; 131: 1735-1741.
16. Pereira SP, Langley PG, Williams R. The management of abnormalities of hemostasis in acute liver failure. Semin Liver Dis 1996; 16: 403-414.
17. Owens AP, III, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res 2011; 108: 1284-1297.
18. Key NS. Analysis of tissue factor positive microparticles. Thromb Res 2010; 125( Suppl 1): S42-S45.
19. Morel O, Jesel L, Freyssinet JM, Toti F. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 2011; 31: 15-26.
20. Rautou PE, Bresson J, Sainte-Marie Y, Vion AC, Paradis V, Renard JM, et al. Abnormal plasma microparticles impair vasoconstrictor responses in patients with cirrhosis. Gastroenterology 2012; 143: 166-176.
21. Meziani F, Delabranche X, Asfar P, Toti F. Bench-to-bedside review: circulating microparticles-a new player in sepsis? Crit Care 2010; 14: 236.
22. Kramer DJ, Canabal JM, Arasi LC. Application of intensive care medicine principles in the management of the acute liver failure patient. Liver Transpl 2008; 14( Suppl 2): S85-S89.
23. Gabriel DA, Giordano K. Microparticle sizing and counting using light scattering methods. Semin Thromb Hemost 2010; 36: 824-832.
24. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874.
25. Lee RD, Barcel DA, Williams JC, Wang JG, Boles JC, Manly DA, et al. Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity. Thromb Res 2012; 129: 80-85.
26. Lacroix R, Robert S, Poncelet P, Kasthuri RS, Key NS, Dignat-George F. Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 2010; 8: 2571-2574.
27. Amabile N, Rautou PE, Tedgui A, Boulanger CM. Microparticles: key protagonists in cardiovascular disorders. Semin Thromb Hemost 2010; 36: 907-916.
28. Chironi GN, Boulanger CM, Simon A, Gnat-George F, Freyssinet JM, Tedgui A. Endothelial microparticles in diseases. Cell Tissue Res 2009; 335: 143-151.
29. Chironi GN, Simon A, Boulanger CM, Gnat-George F, Hugel B, Megnien JL, et al. Circulating microparticles may influence early carotid artery remodeling. J Hypertens 2010; 28: 789-796.
30. Kornek M, Schuppan D. Microparticles: modulators and biomarkers of liver disease. J Hepatol 2012; 57: 1144-1146.
31. Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991; 324: 1852-1857.
32. Harrison P, Wendon J, Williams R. Evidence of increased guanylate cyclase activation by acetylcysteine in fulminant hepatic failure. HEPATOLOGY 1996; 23: 1067-1072.
33. Williams AM, Langley PG, Osei-Hwediah J, Wendon JA, Hughes RD. Hyaluronic acid and endothelial damage due to paracetamol-induced hepatotoxicity. Liver Int 2003; 23: 110-115.
34. Kornek M, Popov Y, Libermann TA, Afdhal NH, Schuppan D. Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells. HEPATOLOGY 2011; 53: 230-242.
35. Kornek M, Lynch M, Mehta SH, Lai M, Exley M, Afdhal NH, et al. Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. Gastroenterology 2012; 143: 448-458.
36. Hirata K, Ogata I, Ohta Y, Fujiwara K. Hepatic sinusoidal cell destruction in the development of intravascular coagulation in acute liver failure of rats. J Pathol 1989; 158: 157-165.
37. Fujiwara K, Ogata I, Ohta Y, Hirata K, Oka Y, Yamada S, et al. Intravascular coagulation in acute liver failure in rats and its treatment with antithrombin III. Gut 1988; 29: 1103-1108.
38. Manly DA, Wang J, Glover SL, Kasthuri R, Liebman HA, Key NS, et al. Increased microparticle tissue factor activity in cancer patients with venous thromboembolism. Thromb Res 2010; 125: 511-512.
39. Shet AS, Aras O, Gupta K, Hass MJ, Rausch DJ, Saba N, et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003; 102: 2678-2683.
40. Aras O, Shet A, Bach RR, Hysjulien JL, Slungaard A, Hebbel RP, et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 2004; 103: 4545-4553.